Vanda Pharmaceuticals (VNDA) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Vanda Pharmaceuticals (VNDA) over the last 15 years, with Q4 2025 value amounting to $12.6 million.
- Vanda Pharmaceuticals' Accumulated Depreciation & Amortization rose 906.89% to $12.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.6 million, marking a year-over-year increase of 906.89%. This contributed to the annual value of $12.6 million for FY2025, which is 906.89% up from last year.
- Per Vanda Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $12.6 million for Q4 2025, which was up 906.89% from $11.6 million recorded in Q4 2024.
- Vanda Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $12.6 million for Q4 2025, and its period low was $9.4 million during Q4 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $11.0 million, with a median of $11.2 million in 2023.
- Per our database at Business Quant, Vanda Pharmaceuticals' Accumulated Depreciation & Amortization soared by 1680.37% in 2021 and then surged by 345.23% in 2024.
- Vanda Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $9.4 million in 2021, then rose by 11.11% to $10.4 million in 2022, then increased by 7.31% to $11.2 million in 2023, then rose by 3.45% to $11.6 million in 2024, then rose by 9.07% to $12.6 million in 2025.
- Its last three reported values are $12.6 million in Q4 2025, $11.6 million for Q4 2024, and $11.2 million during Q4 2023.